LabCorp to Webcast Its Annual Meeting of Shareholders

BURLINGTON, N.C. --(BUSINESS WIRE)--May 3, 2018-- LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 10, 2018 at 9:00 a.m. Eastern Daylight Time via the Company website at www.labcorp.com . An archived replay of the audio webcast will be

LabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid Dependency

Combination of LabCorp’s testing and The Recovery Platform’s software supports compliance with medication-assisted treatment BURLINGTON, N.C. --(BUSINESS WIRE)--May 1, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, and The Recovery Platform are announcing a new collaboration to

LabCorp Enters into Definitive Agreement to Sell Covance Food Solutions to Eurofins for $670 Million

Transaction reflects LabCorp’s mission to improve health and improve lives, and Eurofins’ commitment to be a scientific leader in laboratory services for the food supply industry BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 30, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company,

LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance

Effective January 1, 2018 , the Company adopted the new revenue recognition accounting standard (ASC 606) and restated financial results for 2016 and 2017. Unless otherwise indicated, all financial results in 2017 and comparisons to financial results in 2017 have been restated in these bullets and

LabCorp and Mount Sinai Health System Enhance Laboratory Operations to Improve Patient Care

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 24, 2018-- LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced a significant milestone in achieving their common goal of improving laboratory services and patient care. LabCorp, a leading global life sciences company, and Mount Sinai, one

LabCorp at Walgreens Expands into Florida

Ten new patient service centers to open at Walgreens stores in April and May DEERFIELD, Ill. & BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 23, 2018-- Walgreens and LabCorp® (NYSE: LH) today announced the expansion of their LabCorp at Walgreens collaboration into Florida .

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 2, 2018-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

LabCorp and Appalachian Regional Healthcare Create Comprehensive Laboratory Collaboration

LabCorp’s Expertise in Health System Collaborations will Benefit Patients across Eastern Kentucky and Southern West Virginia BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 22, 2018-- LabCorp® (NYSE: LH) and Appalachian Regional Healthcare have entered into a multi-year, comprehensive laboratory

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 12, 2018-- LabCorp® (NYSE: LH) announced today that for the period of March 12, 2018 to September 11, 2018 , its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will accrue (subject to the terms of the Zero Coupon Notes) contingent

Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development

Global Team Addresses the Unique Scientific Needs of Safety Assessment for Biologics BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 9, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has formed a global immunology